10:00 am – 10:06 am: Patient-Reported Symptoms versus Clinician-Measured Signs to Distinguish Sjogren's in Patients with Dry Eye. Michela Montecchi-Palmer, PhD

10:06 am – 10:12 am: Diagnostic Journey, Care Coordination, and Patient Subtypes for Sjögren’s Disease. Alexander Keenan, MA, MHP

10:12 am – 10:18 am: Dazdotuftide: A Novel Treatment for Non-Infectious Uveitis Demonstrating a Superior IOP Safety Profile. David S Chu, MD

10:18 am – 10:24 am: Acute Invasive Fungal Rhino-Orbital Sinusitis: Lessons Learned and the Path Forward. M. Reza Vagefi, MD

10:24 am – 10:30 am: Prediction of Treatment Response Using Artificial Intelligence in Birdshot Chorioretinopathy. Lingling Huang, MD

10:30 am – 10:36 am: Increased 5-Year Risk of Secondary Complications in Herpetic vs Non-Herpetic Anterior Uveitis. Amber Kwon, BA

10:36 am – 10:42 am: Factors Associated with Adalimumab Initiation in Non-Infectious Uveitis. Rupesh Agrawal, MD, FRCS

10:42 am – 10:48 am: Immunological Heterogeneity in Sarcoidosis: Systemic and Ocular Insights. Sean Lim, MD

10:48 am – 10:54 am: Efficacy and Safety of Vamikibart in Uveitic Macular Edema. Quan Dong Nguyen, MD, MSc

10:54 am – 11:00 am: Effect of Intravitreal Complement Inhibitor on Ganglion Cell Complex Over Time. Sarah Guo, MD

11:00 am – 11:06 am: Safety and Efficacy of Office-Based Vitreoretinal Surgery. David RP Almeida, MD, MBA, PhD

11:06 am – 11:12 am: Pharmacologic Techniques for the Management of Proliferative Vitreoretinopathy. Charles DeBoer, MD, PhD

11:12 – 11:18 am: Ixoberogene Soroparvovec (Ixo-vec) Gene Therapy for nAMD: Long-Term OPTIC Results. Quan Dong Nguyen, MD, MsC